Beyond malignant tumors, increased levels of CA-125 have been observed in conditions such as early pregnancy, peritonitis, menstruation, nephrotic syndrome, endometriosis, leukemia, congestive heart failure, liver cirrhosis, pulmonary vascular disease, rheumatoid arthritis, and tuberculosis (7). This evidence concerns the gene MUC16 and tuberculosis.